DR. LIVINGSTONE A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  3.2% 5.8% 3.6% 5.2% 4.1%  
Credit score (0-100)  57 39 51 42 48  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  -0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Gross profit  -27.9 -39.7 -28.0 -26.5 -29.6  
EBITDA  -27.9 -39.7 -28.0 -26.5 -29.6  
EBIT  -27.9 -39.7 -28.0 -26.5 -29.6  
Pre-tax profit (PTP)  -368.7 -777.0 -510.3 -884.8 -701.1  
Net earnings  -368.7 -777.0 -510.3 -884.8 -701.1  
Pre-tax profit without non-rec. items  -369 -777 -510 -885 -701  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  9.8 289 341 0.0 0.0  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,985 9,005 9,914 8,005 8,131  

Net Debt  -12.3 -0.7 -1.5 -1.5 -3.1  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -27.9 -39.7 -28.0 -26.5 -29.6  
Gross profit growth  -0.3% -42.3% 29.5% 5.4% -11.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,985 9,005 9,914 8,005 8,131  
Balance sheet change%  -15.2% 12.8% 10.1% -19.3% 1.6%  
Added value  -27.9 -39.7 -28.0 -26.5 -29.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.8% -5.3% -1.6% -5.5% -4.6%  
ROI %  -6.4% -301.7% -48.5% -287.7% 0.0%  
ROE %  -33.5% -519.7% -161.9% -518.9% -70,114,100.0%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  0.1% 3.2% 3.4% 0.0% 0.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  44.1% 1.8% 5.3% 5.6% 10.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  794,061.3% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  12.3 0.7 1.5 1.5 3.1  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -7,963.2 -8,714.9 -9,572.0 -8,003.2 -8,127.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0